Clinical Trial Update: 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a 68Ga-NODAGA-E[c(RGDγK)]2 PET tracer for imaging angiogenesis in chronic ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• 68Ga-NODAGA-E[c(RGDγK)]2

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Chronic Ischemic Heart Disease | Phase 2 | Status: UNKNOWN